LL-37 5 mg

Steroids Dragon Pharma Peptide

$26.40

LL-37 5 mg – Peptide Hubs

LL-37 is a naturally occurring antimicrobial peptide (AMP) that plays a vital role in the human innate immune system. As the only known human cathelicidin peptide, LL-37 is involved in bacterial, viral, and fungal defense as well as in tissue healing and inflammation modulation. Peptide Hubs provides high-purity LL-37 in a 5 mg lyophilized vial for use in immune, dermatological, and regenerative research.

Mechanism of Action

LL-37 acts by disrupting the membranes of pathogens through electrostatic interactions, leading to bacterial cell lysis. Beyond antimicrobial activity, LL-37 also influences chemotaxis, angiogenesis, and epithelial cell proliferation, making it relevant in wound healing and immune surveillance models. For more information, see this NIH article on LL-37 functions in immunity.

Research Applications

Broad-spectrum antimicrobial activity studies
Skin repair and chronic wound healing models
Respiratory epithelial defense research (e.g., sinusitis, lung injury)
Modulation of inflammatory cytokines and immune response

LL-37 is often co-researched with GHK Basic for epithelial and collagen regeneration, or Chonluten for respiratory inflammation studies. Some researchers explore combined protocols with L-Glutathione for oxidative defense, or B7-33 for tissue remodeling in fibrotic conditions.

Dispatched within 24 hours in plain, discreet packaging.

Additional Information

Categories:

Steroids

Brand: Dragon Pharma

Manufacturer: Dragon Pharma

Dosage Info: <div class="tab-pane fade" id="offer-tabbody--dosage-and-usage" role="tabpanel"> <section class="tab-panel" id="panel-usage"> <h2>Dosage & Usage Guidelines</h2> <ul> <li><strong>Dosage:</strong> 100–500 mcg daily depending on study</li> <li><strong>Administration:</strong> Subcutaneous or intradermal injection</li> <li><strong>Cycle Duration:</strong> 1–4 weeks in immune or tissue repair models</li> </ul> <h3>Stacking Recommendations</h3> <ul> <li>DSIP – for immune support during recovery and anti-inflammatory balance</li> <li>FOX04-DRI – in aging-related immunomodulatory pathways</li> <li>Cardiogen – for vascular healing under oxidative stress models</li> <li>Semaglutide – for studies involving immune-metabolic regulation</li> </ul> <h3>Safety & Legal Status</h3> <p>LL-37 is a synthetic peptide intended strictly for <strong>research use only</strong> and is not FDA-approved. It shows no toxicity, does not aromatize, and has no hormonal interaction. It is well tolerated in skin, immune, and epithelial models. For active trials and data, refer to <a href="https://clinicaltrials.gov/" rel="noopener" target="_blank">ClinicalTrials.gov</a>.</p> </section> </div>

Reviews:

(0 customer reviews)